282 related articles for article (PubMed ID: 17285618)
1. Successful repeat therapy with rituximab for relapsed thrombotic thrombocytopenic purpura.
Patino W; Sarode R
J Clin Apher; 2007 Feb; 22(1):17-20. PubMed ID: 17285618
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of severe thrombotic thrombocytopenic purpura with the monoclonal antibody rituximab.
Chemnitz J; Draube A; Scheid C; Staib P; Schulz A; Diehl V; Söhngen D
Am J Hematol; 2002 Oct; 71(2):105-8. PubMed ID: 12353309
[TBL] [Abstract][Full Text] [Related]
3. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases.
Koulova L; Alexandrescu D; Dutcher JP; O'Boyle KP; Eapen S; Wiernik PH
Am J Hematol; 2005 Jan; 78(1):49-54. PubMed ID: 15609292
[TBL] [Abstract][Full Text] [Related]
4. Rituximab in the treatment of relapsed thrombotic thrombocytopenic purpura.
Reddy PS; Deauna-Limayo D; Cook JD; Ganguly SS; Blecke C; Bodensteiner DC; Skikne BS; Sahud MA
Ann Hematol; 2005 Apr; 84(4):232-5. PubMed ID: 15517266
[TBL] [Abstract][Full Text] [Related]
5. Role of splenectomy in patients with refractory or relapsed thrombotic thrombocytopenic purpura.
Aqui NA; Stein SH; Konkle BA; Abrams CS; Strobl FJ
J Clin Apher; 2003; 18(2):51-4. PubMed ID: 12874815
[TBL] [Abstract][Full Text] [Related]
6. Response to rituximab in a refractory case of thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus.
Niaz FA; Aleem A
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):109-12. PubMed ID: 20061703
[TBL] [Abstract][Full Text] [Related]
7. Anti-CD20 antibody in thrombotic thrombocytopenic purpura refractory to plasma exchange.
Chow KV; Carroll R; Branley P; Nicholls K; Becker G; Hogan C
Intern Med J; 2007 May; 37(5):329-32. PubMed ID: 17504282
[TBL] [Abstract][Full Text] [Related]
8. Cardiogenic shock complicates successful treatment of refractory thrombotic thrombocytopenia purpura with rituximab.
Millward PM; Bandarenko N; Chang PP; Stagg KF; Afenyi-Annan A; Hay SN; Brecher ME
Transfusion; 2005 Sep; 45(9):1481-6. PubMed ID: 16131381
[TBL] [Abstract][Full Text] [Related]
9. Long-term response to rituximab in patients with relapsing thrombotic thrombocytopenic purpura.
Stein GY; Blickstein D; Orlin J; Sarig G; Inbal A
Isr Med Assoc J; 2011 Jul; 13(7):398-401. PubMed ID: 21838180
[TBL] [Abstract][Full Text] [Related]
10. Rituximab treatment of thrombotic thrombocytopenic purpura in the setting of connective tissue disease.
Niewold TB; Alpert D; Scanzello CR; Paget SA
J Rheumatol; 2006 Jun; 33(6):1194-6. PubMed ID: 16755668
[TBL] [Abstract][Full Text] [Related]
11. Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura (TTP).
Ahmad A; Aggarwal A; Sharma D; Dave HP; Kinsella V; Rick ME; Schechter GP
Am J Hematol; 2004 Oct; 77(2):171-6. PubMed ID: 15389904
[TBL] [Abstract][Full Text] [Related]
12. Successful remission of thrombotic thrombocytopenic purpura with rituximab in a patient with undifferentiated connective tissue disorder.
Gupta D; Roppelt H; Bowers B; Kunz D; Natarajan M; Gruber B
J Clin Rheumatol; 2008 Apr; 14(2):94-6. PubMed ID: 18391679
[TBL] [Abstract][Full Text] [Related]
13. A 14-Year Experience in the Management of Patients with Acquired Immune Thrombotic Thrombocytopenic Purpura in Northern Israel.
Rinott N; Mashiach T; Horowitz NA; Schliamser L; Sarig G; Keren-Politansky A; Dann EJ
Acta Haematol; 2015; 134(3):170-6. PubMed ID: 25997685
[TBL] [Abstract][Full Text] [Related]
14. Membranous nephropathy and thrombotic thrombocytopenic purpura treated with rituximab.
Kuppachi S; Chander P; Yoo J
J Nephrol; 2009; 22(4):561-4. PubMed ID: 19662613
[TBL] [Abstract][Full Text] [Related]
15. Rituximab can be combined with daily plasma exchange to achieve effective B-cell depletion and clinical improvement in acute autoimmune TTP.
Darabi K; Berg AH
Am J Clin Pathol; 2006 Apr; 125(4):592-7. PubMed ID: 16627268
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center.
Froissart A; Buffet M; Veyradier A; Poullin P; Provôt F; Malot S; Schwarzinger M; Galicier L; Vanhille P; Vernant JP; Bordessoule D; Guidet B; Azoulay E; Mariotte E; Rondeau E; Mira JP; Wynckel A; Clabault K; Choukroun G; Presne C; Pourrat J; Hamidou M; Coppo P;
Crit Care Med; 2012 Jan; 40(1):104-11. PubMed ID: 21926591
[TBL] [Abstract][Full Text] [Related]
17. Long-term remission of recurrent thrombotic thrombocytopenic purpura (TTP) after Rituximab in children and young adults.
Wieland I; Kentouche K; Jentzsch M; Lothschütz D; Graf N; Sykora KW
Pediatr Blood Cancer; 2015 May; 62(5):823-9. PubMed ID: 25623397
[TBL] [Abstract][Full Text] [Related]
18. Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long-term follow-up results.
Medeot M; Zaja F; Vianelli N; Battista M; Baccarani M; Patriarca F; Soldano F; Isola M; De Luca S; Fanin R
Eur J Haematol; 2008 Sep; 81(3):165-9. PubMed ID: 18510702
[TBL] [Abstract][Full Text] [Related]
19. Rituximab maintenance for relapsed refractory thrombotic thrombocytopenic purpura.
Bhagirath VC; Kelton JG; Moore J; Arnold DM
Transfusion; 2012 Dec; 52(12):2517-23. PubMed ID: 22486316
[TBL] [Abstract][Full Text] [Related]
20. Splenectomy for the treatment of thrombotic thrombocytopenic purpura.
Kappers-Klunne MC; Wijermans P; Fijnheer R; Croockewit AJ; van der Holt B; de Wolf JT; Löwenberg B; Brand A
Br J Haematol; 2005 Sep; 130(5):768-76. PubMed ID: 16115135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
